Profile
| Metric | Value |
|---|---|
| Full Name | Amneal Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AMRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amneal.com |
| Employees | 8,300 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.13 | |
| Price, 1D Change | -0.42% | |
| $4B | ||
| - | ||
| 1,002.13 | ||
| 0.87 | ||
| $3B | ||
| Revenue, 1Y Change | +16.73% | |
| -$0.38 | ||
| EPS, 1Y Change | +20.68% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.38 | ||
| EPS Estimate | $0.80 | |
| EPS Est. Change | +310.55% | |
| $2.79B | ||
| Revenue Estimate | $3.01B | |
| Revenue Est. Change | +7.75% | |
| Current Price | $14.13 | |
| Price Target | - | $15.00 |
| Price Tgt. Change | - | +6.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.59 | -$0.48 | -180.83% | |
| $0.61 | -$0.38 | -161.78% | |
| $0.80 | N/A | +310.55% | |
| $0.94 | N/A | +347.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.41B | $2.39B | -0.71% | |
| $2.77B | $2.79B | +0.81% | |
| $3.01B | N/A | +7.75% | |
| $3.21B | N/A | +14.72% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.13 | |
| $9.87 | ||
| SMA 200 vs Price | -30.17% | |
| $12.77 | ||
| SMA 50 vs Price | -9.60% | |
| 0.87 | ||
| $0.45 | ||
| 66.63 | ||
| 32.91% | ||
| 32.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.79B | ||
| -$0.38 | ||
| $1.02B | ||
| 36.52% | ||
| $353.29M | ||
| -50.83% | ||
| -$73.88M | ||
| -2.64% | ||
| $589.48M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -23.73 | ||
| 1.41 | ||
| 0.86 | ||
| - | ||
| 6 | ||
| 1.80 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 1,002.13 | ||
| 1.51 | ||
| -40.58 | ||
| 11.40 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$109.27M | ||
| $118.42M | ||
| $3.50B | ||
| $1.59B | ||
| $3.55B | ||
| $1.13B | ||
| $2.59B | ||
| $340.26M | ||
| $258.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.91B | ||
| $667.15M | ||
| $1.77B | ||
| $0.00 | ||
| $236.19M | ||
| $0.00 | ||
| $18.86M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $295.03M | ||
| -$63.00M | ||
| -$211.72M | ||
| $74.99M | ||
| $220.04M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Piper Sandler | → | |
| JP Morgan | → | |
| Barclays | → | |
| JP Morgan | → | |
| Piper Sandler | → | |
| Truist Securities | → | |
| JP Morgan | → | |
| Barclays | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
Screeners with AMRX
FAQ
What is the ticker symbol for Amneal Pharmaceuticals, Inc.?
The ticker symbol for Amneal Pharmaceuticals, Inc. is NASDAQ:AMRX
Does Amneal Pharmaceuticals, Inc. pay dividends?
No, Amneal Pharmaceuticals, Inc. does not pay dividends
What sector is Amneal Pharmaceuticals, Inc. in?
Amneal Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Amneal Pharmaceuticals, Inc. in?
Amneal Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Amneal Pharmaceuticals, Inc. based in?
Amneal Pharmaceuticals, Inc. is headquartered in United States
When did Amneal Pharmaceuticals, Inc. go public?
Amneal Pharmaceuticals, Inc. initial public offering (IPO) was on May 7, 2018
Is Amneal Pharmaceuticals, Inc. in the S&P 500?
No, Amneal Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Amneal Pharmaceuticals, Inc. in the NASDAQ 100?
No, Amneal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Amneal Pharmaceuticals, Inc. in the Dow Jones?
No, Amneal Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Amneal Pharmaceuticals, Inc. last earnings report?
Amneal Pharmaceuticals, Inc.'s most recent earnings report was on October 30, 2025
When does Amneal Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Amneal Pharmaceuticals, Inc. is February 27, 2026
Data Sources & References
- AMRX Official Website www.amneal.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
- AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
- AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx